EGM

Encore Global Management Portfolio holdings

AUM $102M Turnover 33.78%
This Fund
S&P 500
This Quarter Est. Return
+21.92%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$41.4M
Cap. Flow
-$52.7M
Cap. Flow %
-51.72%
Top 10 Hldgs %
40.03%
Holding
74
New
4
Increased
15
Reduced
19
Closed
21
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.69M
2
ZTS icon
Zoetis
ZTS
+$2.26M
3
CRSP icon
CRISPR Therapeutics
CRSP
+$1.61M
4
BSX icon
Boston Scientific
BSX
+$1.48M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.44M

Top Sells

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$4.89M
2
MRVL icon
Marvell Technology
MRVL
+$4.75M
3
BP icon
BP
BP
+$4.41M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.4M
5
NTRS icon
Northern Trust
NTRS
+$3.36M

Sector Composition

Rank Sector Weight
1 Technology 42.38%
2 Healthcare 17.18%
3 Energy 10.16%
4 Communication Services 10.03%
5 Financials 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.96T
$5.32M 5.22%
14,250
+1,300
+10% +$526K
2026 Q1
1 quarter
PANW icon
2
Palo Alto Networks
PANW
$307B
$5.12M 5.02%
15,000
-10,550
-41% -$2.41M
2026 Q1
1 quarter
META icon
3
Meta Platforms (Facebook)
META
$1.88T
$4.37M 4.29%
7,750
-1,000
-11% -$611K
2026 Q1
1 quarter
NVDA icon
4
NVIDIA
NVDA
$5.34T
$4.1M 4.03%
20,500
– –
2026 Q1
1 quarter
AMZN icon
5
Amazon
AMZN
$2.74T
$3.93M 3.86%
16,500
– –
2026 Q1
1 quarter
TMO icon
6
Thermo Fisher Scientific
TMO
$249B
$3.81M 3.74%
7,600
+3,000
+65% +$1.44M
2026 Q1
1 quarter
QCOM icon
7
Qualcomm
QCOM
$184B
$3.61M 3.54%
19,530
-4,670
-19% -$873K
2026 Q1
1 quarter
CRM icon
8
Salesforce
CRM
$194B
$3.52M 3.46%
22,500
+880
+4% +$155K
2026 Q1
1 quarter
CHTR icon
9
Charter Communications
CHTR
$12B
$3.52M 3.45%
24,750
+8,250
+50% +$1.38M
2026 Q1
1 quarter
AMD icon
10
Advanced Micro Devices
AMD
$932B
$3.49M 3.42%
6,000
-4,500
-43% -$1.84M
2026 Q1
1 quarter
OKTA icon
11
Okta
OKTA
$37B
$3.44M 3.38%
25,200
-300
-1% -$28.2K
2026 Q1
1 quarter
REGN icon
12
Regeneron Pharmaceuticals
REGN
$80.1B
$3.15M 3.09%
5,050
+3,950
+359% +$2.69M
2026 Q1
1 quarter
BSX icon
13
Boston Scientific
BSX
$62.3B
$3.15M 3.09%
73,700
+27,200
+58% +$1.48M
2026 Q1
1 quarter
MRVL icon
14
Marvell Technology
MRVL
$220B
$3.13M 3.07%
10,500
-23,700
-69% -$4.75M
2026 Q1
1 quarter
NOW icon
15
ServiceNow
NOW
$145B
$3.13M 3.07%
31,500
+6,100
+24% +$604K
2026 Q1
1 quarter
ET icon
16
Energy Transfer Partners
ET
$69.7B
$2.94M 2.89%
154,000
-35,000
-19% -$678K
2026 Q1
1 quarter
ZTS icon
17
Zoetis
ZTS
$31.1B
$2.73M 2.68%
38,000
+24,000
+171% +$2.26M
2026 Q1
1 quarter
CHWY icon
18
Chewy
CHWY
$8.37B
$2.62M 2.57%
133,500
+22,000
+20% +$499K
2026 Q1
1 quarter
STT icon
19
State Street
STT
$45.8B
$2.37M 2.33%
14,000
-1,900
-12% -$293K
2026 Q1
1 quarter
BAC icon
20
Bank of America
BAC
$359B
$2.28M 2.24%
40,000
– –
2026 Q1
1 quarter
V icon
21
Visa
V
$735B
$2.06M 2.02%
6,000
– –
2026 Q1
1 quarter
MA icon
22
Mastercard
MA
$528B
$2.05M 2.02%
4,000
+400
+11% +$199K
2026 Q1
1 quarter
IBM icon
23
IBM
IBM
$215B
$2.02M 1.99%
7,200
+1,200
+20% +$302K
2026 Q1
1 quarter
AAPL icon
24
Apple
AAPL
$5.01T
$1.95M 1.92%
6,750
-750
-10% -$215K
2026 Q1
1 quarter
COP icon
25
ConocoPhillips
COP
$171B
$1.77M 1.73%
17,000
– –
2026 Q1
1 quarter
1
2 3

Similar funds

LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
PCP
Pantera Capital Partners San Francisco, California $102M AUM 45.76% 1-Year Est. Return
MC
MSD Capital New York $102M AUM 2.45% 1-Year Est. Return
PWM
Partners Wealth Management Carmel By The Sea, California $102M AUM 23.71% 1-Year Est. Return
ECP
Electric Capital Partners Palo Alto, California $102M AUM
EFA
Englebert Financial Advisers Allentown, Pennsylvania $102M AUM
ACMA
Arbor Capital Management (Alaska) Anchorage, Alaska $102M AUM 14.51% 1-Year Est. Return
GHA
Good Harbor Advisors Gloucester, Massachusetts $102M AUM

Encore Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Encore Global Management held 74 positions worth $102M, down 29% from $143M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Encore Global Management withdrew a net $52.7M in Q2 2026, closing 21 positions and reducing 19 holdings. Its most notable exit was Valero Energy, an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Encore Global Management opened a new position in CRISPR Therapeutics worth $1.67M.

  • Encore Global Management's largest Q2 2026 buy was CRISPR Therapeutics: 30,557 shares worth $1.67M.
  • Encore Global Management added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $2.69M increase.
  • Encore Global Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $4.75M.
  • Encore Global Management fully exited Valero Energy in Q2 2026, selling an estimated $4.89M.
  • Encore Global Management's ten largest holdings make up 40% of its $102M portfolio in Q2 2026.
  • Encore Global Management opened 4 new positions and closed 21 in Q2 2026.
  • Encore Global Management's portfolio value fell 29% quarter-over-quarter to $102M.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.